• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Community treatment with ivermectin for onchocerciasis in the east Usambara mountains.

作者信息

Mwetta E, Hills E

机构信息

Hospital Teule, Muheza, Tanzania.

出版信息

East Afr Med J. 1994 Dec;71(12):790-1.

PMID:7705249
Abstract

Ivermectin 150mcg/kg was given orally to 743 patients with positive skin snips for Onchocerca volvulus and to 697 residents in two villages in the Usambara mountains. 620 villagers attended for a second dose. On direct questioning, 98.7% patients with +ve skin snips and 91.8% villagers given mass chemotherapy admitted to adverse reactions. After a second dose, 16.6% had mild reactions. No serious problems were encountered. 167 of 170 repeat skin snips were negative. Repeated administration of ivermectin is well tolerated and offers a chance of reducing the burden of onchocerciasis in the Usambara mountains.

摘要

相似文献

1
Community treatment with ivermectin for onchocerciasis in the east Usambara mountains.
East Afr Med J. 1994 Dec;71(12):790-1.
2
Adverse reactions to ivermectin treatment in Simulium neavei-transmitted onchocerciasis.在由纳氏蚋传播的盘尾丝虫病中,伊维菌素治疗的不良反应。
Am J Trop Med Hyg. 2003 Dec;69(6):621-3.
3
Chemokines in onchocerciasis patients after a single dose of ivermectin.单剂量伊维菌素治疗后盘尾丝虫病患者体内的趋化因子
Clin Exp Immunol. 2005 Nov;142(2):318-26. doi: 10.1111/j.1365-2249.2005.02910.x.
4
Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.伊维菌素重复治疗对喀麦隆北部盘尾丝虫病发病率的影响。
Am J Trop Med Hyg. 1995 Jul;53(1):63-7.
5
Onchocerciasis and human immunodeficiency virus in western Uganda: prevalences and treatment with ivermectin.乌干达西部的盘尾丝虫病与人类免疫缺陷病毒:患病率及伊维菌素治疗情况
Am J Trop Med Hyg. 1995 Aug;53(2):171-8.
6
Ivermectin--clinical trials and treatment schedules in onchocerciasis.伊维菌素——盘尾丝虫病的临床试验与治疗方案
Acta Leiden. 1990;59(1-2):169-75.
7
Emergence of Onchocerca volvulus microfilariae from skin snips before and after treatment of patients with ivermectin.伊维菌素治疗前后患者皮肤切片中盘尾丝虫微丝蚴的出现情况。
Trop Med Parasitol. 1988 Dec;39(4):313-6.
8
Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly.每年或每三个月使用正常剂量和高剂量伊维菌素治疗盘尾丝虫病的全身性不良反应。
Trans R Soc Trop Med Hyg. 2004 Aug;98(8):496-504. doi: 10.1016/j.trstmh.2003.10.018.
9
Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.三年伊维菌素治疗对巴西亚马逊地区亚诺马米社区盘尾丝虫病的影响。
Acta Trop. 2009 Nov;112(2):125-30. doi: 10.1016/j.actatropica.2009.07.009. Epub 2009 Jul 15.
10
Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.在赤道几内亚比奥科岛进行8年伊维菌素治疗后,按种族和社区划分的盘尾丝虫微丝蚴感染率和感染强度的降低情况。
Trop Med Int Health. 2006 Jul;11(7):1082-91. doi: 10.1111/j.1365-3156.2006.01650.x.

引用本文的文献

1
Onchocerciasis drug development: from preclinical models to humans.盘尾丝虫病药物研发:从临床前模型到人体。
Parasitol Res. 2021 Dec;120(12):3939-3964. doi: 10.1007/s00436-021-07307-4. Epub 2021 Oct 13.